The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation

The Effect Of Lasofoxifene On Local Mediators Of Bone Resorption In The Prevention Of Postmenopausal Osteoporosis

The objective of the study is to demonstrate the effects that lasofoxifene has on serum markers of bone metabolism.

Inclusion Criteria:

• Postmenopausal women over 50 years who have low bone mineral density.

Exclusion Criteria:

• Women who are under 50 years of age, are premenopausal, or who currently have osteoporosis are excluded.